Company registration number SC517081 (Scotland)
CLINNOVATE HEALTH UK LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
CLINNOVATE HEALTH UK LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
CLINNOVATE HEALTH UK LIMITED
BALANCE SHEET
AS AT 30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
-
0
124,393
Current assets
Debtors
5
-
0
39,696
Cash at bank and in hand
73,997
17,384
73,997
57,080
Creditors: amounts falling due within one year
6
(50,720)
(55,829)
Net current assets
23,277
1,251
Total assets less current liabilities
23,277
125,644
Creditors: amounts falling due after more than one year
7
-
0
(61,528)
Net assets
23,277
64,116
Capital and reserves
Called up share capital
8
1,000
1,000
Profit and loss reserves
22,277
63,116
Total equity
23,277
64,116

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 24 March 2026
Serene Lek
Director
Company registration number SC517081 (Scotland)
CLINNOVATE HEALTH UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
1
Accounting policies
Company information

Clinnovate Health UK Limited is a private company limited by shares incorporated in Scotland. The registered office is Imaging Centre of Excellence, Level 3.18, 1345 Govan Road, Glasgow, G51 4TF.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The company ceased trading on 30 September 2025 and the directors intend to realise the company’s assets and settle its liabilities in the normal course of winding up. Accordingly, the financial statements have been prepared on a break-up basis.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Leasehold
2% Straight line
Fixtures, fittings & equipment
15% Straight line
Computer equipment
20% Reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

CLINNOVATE HEALTH UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 3 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.9
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

CLINNOVATE HEALTH UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 4 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 October 2024
138,696
964
139,660
Disposals
(138,696)
(964)
(139,660)
At 30 September 2025
-
0
-
0
-
0
Depreciation and impairment
At 1 October 2024
14,333
934
15,267
Depreciation charged in the year
-
0
30
30
Eliminated in respect of disposals
(14,333)
(964)
(15,297)
At 30 September 2025
-
0
-
0
-
0
Carrying amount
At 30 September 2025
-
0
-
0
-
0
At 30 September 2024
124,363
30
124,393
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
-
0
39,696
CLINNOVATE HEALTH UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 5 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
-
0
11,230
Trade creditors
147
6,213
Taxation and social security
1,793
-
0
Other creditors
48,780
38,386
50,720
55,829
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
-
0
61,528

The bank loan is secured by a floating charge over all assets of the company in favour of HSBC UK Bank.

8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 0.1p each
1,000,000
1,000,000
1,000
1,000
2025-09-30 2024-10-01 false false false 24 March 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Serene Lek SC517081 2024-10-01 2025-09-30 SC517081 2025-09-30 SC517081 2024-09-30 SC517081 core:LandBuildings 2025-09-30 SC517081 core:OtherPropertyPlantEquipment 2025-09-30 SC517081 core:LandBuildings 2024-09-30 SC517081 core:OtherPropertyPlantEquipment 2024-09-30 SC517081 core:WithinOneYear 2025-09-30 SC517081 core:WithinOneYear 2024-09-30 SC517081 core:AfterOneYear 2025-09-30 SC517081 core:AfterOneYear 2024-09-30 SC517081 core:CurrentFinancialInstruments 2025-09-30 SC517081 core:CurrentFinancialInstruments 2024-09-30 SC517081 core:ShareCapital 2025-09-30 SC517081 core:ShareCapital 2024-09-30 SC517081 core:RetainedEarningsAccumulatedLosses 2025-09-30 SC517081 core:RetainedEarningsAccumulatedLosses 2024-09-30 SC517081 core:ShareCapitalOrdinaryShareClass1 2025-09-30 SC517081 core:ShareCapitalOrdinaryShareClass1 2024-09-30 SC517081 bus:Director1 2024-10-01 2025-09-30 SC517081 core:LandBuildings core:LongLeaseholdAssets 2024-10-01 2025-09-30 SC517081 core:FurnitureFittings 2024-10-01 2025-09-30 SC517081 core:ComputerEquipment 2024-10-01 2025-09-30 SC517081 2023-06-01 2024-09-30 SC517081 core:LandBuildings 2024-09-30 SC517081 core:OtherPropertyPlantEquipment 2024-09-30 SC517081 2024-09-30 SC517081 core:LandBuildings 2024-10-01 2025-09-30 SC517081 core:OtherPropertyPlantEquipment 2024-10-01 2025-09-30 SC517081 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 SC517081 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 SC517081 core:Non-currentFinancialInstruments 2025-09-30 SC517081 core:Non-currentFinancialInstruments 2024-09-30 SC517081 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 SC517081 bus:OrdinaryShareClass1 2025-09-30 SC517081 bus:OrdinaryShareClass1 2024-09-30 SC517081 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 SC517081 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 SC517081 bus:FRS102 2024-10-01 2025-09-30 SC517081 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 SC517081 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP